SciSparc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SciSparc and other ETFs, options, and stocks.

About SPRC

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. 

CEO
Oz Adler
CEOOz Adler
Employees
2
Employees2
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2004
Founded2004
Employees
2
Employees2

SPRC Key Statistics

Market cap
3.33M
Market cap3.33M
Price-Earnings ratio
-0.16
Price-Earnings ratio-0.16
Dividend yield
Dividend yield
Average volume
371.65K
Average volume371.65K
High today
$0.3121
High today$0.3121
Low today
$0.272
Low today$0.272
Open price
$0.3121
Open price$0.3121
Volume
285.21K
Volume285.21K
52 Week high
$1.79
52 Week high$1.79
52 Week low
$0.197
52 Week low$0.197

People also own

Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.